1. Zhang, Lisheng, Huang, Yan, Yang, Yanting, Gu, Jiangyong, Zhang, Ren. 2024. TIMM9 as a prognostic biomarker in multiple cancers and its associated biological processes. In Scientific reports, 14, 20568. doi:10.1038/s41598-024-71421-3. https://pubmed.ncbi.nlm.nih.gov/39232081/
2. Ma, Keqiang, Wu, Hongsheng, Ji, Lei. 2023. Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma. In Frontiers in genetics, 13, 1065644. doi:10.3389/fgene.2022.1065644. https://pubmed.ncbi.nlm.nih.gov/36685852/
3. Chen, Weigang, Yang, Zelong, Chen, Yong. 2022. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma. In Disease markers, 2022, 3594901. doi:10.1155/2022/3594901. https://pubmed.ncbi.nlm.nih.gov/36105252/
4. Svagusa, T, Sikiric, S, Milavic, M, Bakovic, P, Sedlic, F. 2023. Heart failure in patients is associated with downregulation of mitochondrial quality control genes. In European journal of clinical investigation, 53, e14054. doi:10.1111/eci.14054. https://pubmed.ncbi.nlm.nih.gov/37403271/